
Second Sight Medical Products EYES
Annual report 2025
added 03-26-2026
Second Sight Medical Products DPO Ratio 2011-2026 | EYES
Annual DPO Ratio Second Sight Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.6 | 21 | 24.1 | - | - | -355 | 185 | 97.4 | 53.6 | 41.9 | 49 | 52.6 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 185 | -355 | 20 |
Quarterly DPO Ratio Second Sight Medical Products
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.8 | 43.7 | 30.8 | - | 23.3 | 20.8 | 19.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 274 | 107 | 150 | - | 66.8 | 142 | 140 | - | 68.5 | 60.9 | - | - | - | - | 93.4 K | - | 85.6 | 20.7 | 18.1 K | - | 112 | 47.1 | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 93.4 K | 19.4 | 5.38 K |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ClearPoint Neuro
CLPT
|
33.2 | $ 9.23 | -1.6 % | $ 261 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.46 | - | $ 130 M | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.07 | - | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
FONAR Corporation
FONR
|
16.6 | $ 18.6 | - | $ 122 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
46.4 | $ 36.66 | -0.22 % | $ 5.46 K | ||
|
Globus Medical
GMED
|
33.1 | $ 90.0 | 1.58 % | $ 12.2 B | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 1.81 | -4.74 % | $ 1.1 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.25 | -0.64 % | $ 712 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Inspire Medical Systems
INSP
|
103 | $ 54.21 | 0.13 % | $ 1.59 B | ||
|
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.77 | 0.16 % | $ 2.98 B | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.78 | -1.0 % | $ 370 M | ||
|
IRIDEX Corporation
IRIX
|
71.9 | $ 1.01 | 1.85 % | $ 17.1 M | ||
|
LENSAR
LNSR
|
146 | $ 5.82 | -1.27 % | $ 69.6 M | ||
|
Medtronic PLC
MDT
|
76.2 | $ 86.12 | -0.19 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Myomo
MYO
|
34.8 | $ 0.67 | -4.9 % | $ 28 M | ||
|
Align Technology
ALGN
|
33.7 | $ 167.26 | -2.69 % | $ 12.5 B | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
34.4 | $ 31.33 | -4.03 % | $ 1.44 B | ||
|
Orthofix Medical
OFIX
|
76.3 | $ 11.58 | -1.61 % | $ 459 M | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Penumbra
PEN
|
26.1 | $ 329.2 | -0.2 % | $ 12.8 B | ||
|
Insulet Corporation
PODD
|
22.5 | $ 203.09 | -0.2 % | $ 14.3 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
223 | $ 2.49 | -1.58 % | $ 6.91 M | ||
|
Butterfly Network
BFLY
|
51.3 | $ 4.03 | -2.42 % | $ 853 M | ||
|
Smith & Nephew plc
SNN
|
232 | $ 31.88 | -2.3 % | $ 23.8 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
70.1 | $ 331.18 | -0.34 % | $ 127 B | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.59 | 0.69 % | $ 36.7 M | ||
|
Tactile Systems Technology
TCMD
|
24.4 | $ 24.49 | -0.33 % | $ 560 M | ||
|
TELA Bio
TELA
|
31.8 | $ 0.62 | -2.08 % | $ 29.1 M | ||
|
TransMedics Group
TMDX
|
15.5 | $ 104.84 | 0.04 % | $ 3.56 B | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
35.7 | $ 19.55 | 1.98 % | $ 1.33 B | ||
|
Delcath Systems
DCTH
|
56 | $ 9.61 | -0.98 % | $ 344 M | ||
|
Boston Scientific Corporation
BSX
|
61.7 | $ 61.27 | -2.11 % | $ 90.7 B |